Cayman Islands: Intertrust Acts As Administrator On USD300 Mllion European Life Sciences Fund
Last Updated: 24 August 2017

Intertrust, a leading global provider of high value trust, corporate and fund services, has been appointed by Medicxi to provide fund administration, accounting and compliance services to a USD300 million growth fund targeting late state European life sciences companies.

Medicxi, which has offices in London, Geneva and Jersey, is one of the leading independent European life sciences investment firms. The new fund, Medicxi Growth I will fill a clear late-stage funding gap in Europe by offering financial support to life sciences entrepreneurs.

Paul Lawrence, Global Head of Funds at Intertrust, commented: "We have enjoyed a solid relationship with Medicxi, including a successful partnership with Elian prior to its acquisition by Intertrust in 2016. We have a proven track record in providing quality client service and we look forward to continuing to work with Medicxi on this new fund. It's good to see a fund of this nature being raised in the life sciences space and the positive social contribution they deliver."

"The high level of expertise and experience held within our funds team means we continue to broaden and strengthen our relationships with fund managers."

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Intertrust  
By Tania Bearryman
By Laura Da Ascencão
By Paul Lawrence, Michael Johnson
By Alice Lau, Michelle Tang, Aby Wong, Ida Chang
By Anja Grenner
By Paul Lawrence
By Paul Lawrence, Michael Johnson
By Paul Lawrence
By Carl Brenton
Font Size: